Paul Stoffels
Found 3 people in Illinois, California, Pennsylvania and other states
-
+99
-
+98
-
+97
-
-
+95
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
/s3/static.nrc.nl/images/gn4/stripped/data84078882-9bcf87.jpg "Wint Paul Stoffels het vertrouwen in Galapagos terug?")
/s3/static.nrc.nl/images/gn4/stripped/data131242054-b977c2.jpg "Paul Stoffels, topman Galapagos, maakt plaats voor 'de volgende generatie'")
Paul Stoffels - @TispaMedical
Proper diagnosis is impossible on improperly processed tissue. Don't re-use solvents and don't use agitation.
Paul Stoffels - @PaulStoffels3
Grand dad
Sponsored by SpokeoPaid Service
Paul R Stoffels, age 64
P*****@msn.com — (630) 469-****
*****s050 Butternut Ln, Glen Ellyn, IL
View full reportSponsored by SpokeoPaid Service
Paul Stoffels
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
Paul Stoffels - @paul.stoffels
1 follower
Paul Stoffels - @paul.stoffels8
158 followers
Paul Stoffels - @paulstoffels0
32 followers
paulstoffels - @paulstoffels
1 follower
jeanpaulstoffels3 - @jeanpaulstoffels3
1 follower
paulastoffels39 - @paulastoffels39
102 followers
paulomariostoffels5 - @paulomariostoffels5
119 followers
Paula Stoffels08 - @paula.stoffels08
Wholesale High-Quality Branded Jewelry
https://aacollectionshop.com/
9 followers
Paula Stoffels - @paula.stoffels
Co-owner of IRONIK Scrubs
6 followers
Paula Stoffels - @paulastoffels
1 follower
paul - @paulinestoffels
9 followers
Paul Stoffels, MD
Galapagos
Education: University of Antwerp ...
Paul Stoffels
PPD
Paul Stoffels
Senior Consultant at Novexas
Paul Stoffels
Lely
Paul Stoffels
Deutschland
Monica Berrospe
Surgical Technologist at United ...
Hariharan Jeganathan
PAUL STOFFELS
Jörg Paul Stoffels
Randy Bradford
Gregory Simpson, Ph.D.
Michelle Cho
Senior Director, US Medical Affairs
Jenn Lindal
Memories by Design Vacations
Paul Stoffels
Sponsored by PeopleLookerPaid Service
Search for Paul Stoffels's city and state history
Search address historyWebsites owned by Paul Stoffels
apstram.net
Registered on June 5, 2013
tomashake.info
Registered on February 17, 2014
tomador.info
Registered on February 17, 2014
kiwiberrybystoffels.info
Registered on August 27, 2015
tomabox.info
Registered on February 17, 2014
torrito.info
Registered on February 17, 2014
tomalocal.info
Registered on April 24, 2014
automato.info
Registered on May 19, 2015
2mates.info
Registered on February 17, 2014
gusto-tomato.info
Registered on December 9, 2014
Stoffels To Depart Galapagos, Short of Five-Year Mission To Remake the Biotech
BioSpace - Tue, 22 Apr 2025
Paul Stoffels exits Galapagos after three years at the helm
FirstWord Pharma - Tue, 22 Apr 2025
'Gilead wants us to rebuild': Why Galapagos isn't allowed to go extinct after turbulent year
Fierce Biotech - Wed, 19 Nov 2025
Paul Stoffels on retiring from Galapagos; Boehringer Ingelheim switches up leadership
Endpoints News - Fri, 25 Apr 2025
Paul Stoffels to step down as Galapagos CEO
statnews.com - Tue, 22 Apr 2025
Paul Stoffels to retire as CEO of Galapagos but will remain as chairman of the board
The Brussels Times - Tue, 22 Apr 2025
Galapagos sources CEO for oncology spin-off as Stoffels plans exit
The Pharma Letter - Tue, 22 Apr 2025
Former Neumora CEO to lead Galapagos spinout
BioPharma Dive - Tue, 22 Apr 2025
Philips provides update on the Annual General Meeting of Shareholders 2025 Agenda
Philips - Fri, 25 Apr 2025
Galapagos Appoints Founding CEO of Newly Created SpinCo
Contract Pharma - Wed, 23 Apr 2025
Galapagos Takes Dramatic U-Turn, Ditching Spinout Plan, Cell Therapy and CEO Stoffels
BioSpace - Tue, 13 May 2025
Galapagos drops plan to split after 'market developments'
pharmaphorum - Tue, 13 May 2025
Gosebruch becomes Galapagos CEO as company reconsiders proposal to split in two
BioCentury - Wed, 14 May 2025
Updated: To spin off or not to spin off? Galapagos backpedals on separation plans, CEO Paul Stoffels exits early
Endpoints News - Tue, 13 May 2025
Galapagos to Wind Down Cell Therapy Business After Search for a Buyer Comes Up Empty
Dealbreaker - Wed, 22 Oct 2025
Galapagos gets cold feet over plans to split up company
Fierce Biotech - Tue, 13 May 2025
Galapagos COO steps down amid sweeping corporate overhaul
The Pharma Letter - Tue, 15 Apr 2025
Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders
Fierce Biotech - Fri, 25 Apr 2025
JPM26: Galapagos’ New CEO Is Here To Finally Turn the Ship Around
BioSpace - Mon, 19 Jan 2026
J&J science chief Stoffels to retire after decade at the top, adding to C-suite changes
Fierce Biotech - Tue, 12 Oct 2021
Drugmaker Galapagos names former J&J exec Paul Stoffels as CEO
Reuters - Wed, 26 Jan 2022
In Belgium, a native son returns to resurrect the drugmaker Galapagos — and ‘to get the trust back’
statnews.com - Thu, 18 May 2023
In first M&A strike, Paul Stoffels lays out 5-year plan to turn Galapagos around
Fierce Biotech - Thu, 23 Jun 2022
Paul Stoffels, J&J’s former top scientist, to lead Galapagos
BioPharma Dive - Thu, 27 Jan 2022
'Up to Paul now': Galapagos' new CEO Stoffels jumps straight into deal talks, finding a new science chief
Fierce Biotech - Thu, 27 Jan 2022
Galapagos CEO Tells JPM Audience the Rationale for Planned Business Separation
MedCity News - Thu, 16 Jan 2025
Paul Stoffels swiftly resurfaces as Galapagos' next CEO
pharmaphorum - Thu, 27 Jan 2022
J&J's Chief Scientific Officer Paul Stoffels on vaccine candidate results
CNBC - Fri, 29 Jan 2021
9-year J&J science chief Stoffels to steer Galapagos' rebound as CEO
Fierce Biotech - Wed, 26 Jan 2022
Galapagos' new CEO Paul Stoffels wields axe in bid to go 'forward, faster'
pharmaphorum - Fri, 04 Nov 2022
J&J's long-serving R&D chief Paul Stoffels announces retirement
pharmaphorum - Tue, 12 Oct 2021
How Johnson & Johnson is doing its part to tackle the worldwide mental health epidemic
Johnson & Johnson - Thu, 25 Jan 2018
Johnson & Johnson's Top Scientist, Stoffels, to Retire at Year-End
thestreet.com - Tue, 12 Oct 2021
J&J hopes to start human trials for coronavirus vaccine in November
CNBC - Tue, 17 Mar 2020
Top 5 highest paid biopharma R&D executives in 2022
Fierce Biotech - Tue, 30 May 2023
Paul Stoffels Expands The Janssen Legacy
Life Science Leader - Mon, 03 Mar 2014
Galapagos to Spin Out Innovative Medicines, Lay Off 40%
BioSpace - Wed, 08 Jan 2025
J&J’s Chief Scientist Paul Stoffels to Retire at End of 2021
Bloomberg - Tue, 12 Oct 2021
An industry leader in HIV research
IAVI - Wed, 27 Dec 2023
"I was on the ground during the HIV epidemic": Meet the scientist who's sharing the spotlight with celebs at the Global Citizen Festival
Johnson & Johnson - Sat, 29 Sep 2018
Galapagos scraps applications for Jyseleca in Europe and slashes sales projection
Fierce Pharma - Fri, 04 Aug 2023
Former J&J Scientist Paul Stoffels to Lead Galapagos Revival Bid
Bloomberg - Thu, 27 Jan 2022
Galapagos Brings Oncology Focus to Central NJ
Community News - Wed, 15 Jan 2025
The top 10 highest paid biopharma R&D executives in 2021
Fierce Biotech - Tue, 10 May 2022
J&J’s CSO to retire by the end of 2021
drugdiscoverytrends.com - Tue, 12 Oct 2021
With new partnership, Galapagos takes decentralized CAR-T manufacturing quest nationwide
Fierce Pharma - Wed, 15 May 2024
Galapagos unveils plan to split, hiving off its drugs unit
pharmaphorum - Wed, 08 Jan 2025
R&D Funding Is the Best Medicine
Politico - Mon, 13 Jan 2014
Johnson & Johnson shakeup leaves Joaquin Duato with largest portfolio
Fierce Pharma - Mon, 25 Jun 2018
The top 10 highest paid biopharma R&D executives in 2020
Fierce Biotech - Mon, 14 Jun 2021
COVID-19 Vaccine Could Cost As Little As $10 A Dose, Says Janssen
Citeline News & Insights - Thu, 02 Apr 2020
Yoshinori Ohsumi, Ph.D., Wins 2016 Dr. Paul Janssen Award for Biomedical Research
MultiVu - Wed, 08 Jun 2016
Belgium: Stoffels Tomatoes keep consumers in mind
FreshPlaza - Wed, 13 Jun 2012
J&J seals $30bn Swiss Actelion deal
The Peninsula Qatar - Thu, 26 Jan 2017
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Paul Stoffels - @stoffelspaul66
0 followers
Paul Stoffels - @paulstoffelsbvba
0 followers
Jean paul Stoffels - @jeanpaulstoffels
0 followers
Paul Stoffels - @paulstoffels
0 followers
Paul Stoffels - @stoffelspaul4
0 followers
Paul Stoffels - @paulstoffelstab
0 followers
Paul Stoffels - @pauls9469
0 followers
Paul Stoffels - @pauls1983
0 followers
KEI-NIH FOIA Lawsuit for Francis Collins Correspondence - May 2022 Production
US Government, obtained by KEI
2022
KEI-NIH FOIA Lawsuit for NIH-FNIH Correspondence on COVID-19 Partnership - December 2023 Production
US Government, obtained by KEI
2023
KEI-NIH FOIA Lawsuit for NIH-FNIH Correspondence on COVID-19 Partnership - May 2023 Production
US Government, obtained by KEI
2023
KEI-NIH FOIA Lawsuit for NIH-FNIH Correspondence on COVID-19 Partnership - February 2024 Production
US Government, obtained by KEI
2024
KEI-NIH FOIA Lawsuit for Francis Collins Correspondence - April 2022 Production
US Government, obtained by KEI
2022
KEI-NIH FOIA Lawsuit for Francis Collins Correspondence - March 2022 Production
US Government, obtained by KEI
2022
KEI-NIH FOIA Lawsuit for NIH-FNIH Correspondence on COVID-19 Partnership - November 2023 Production
US Government, obtained by KEI
2023
johnson johnson pharma business review release may 23 2013 0
Dena Vorzman
2013
KEI-NIH FOIA Lawsuit for NIH-FNIH Correspondence on COVID-19 Partnership - January 2023 Production
US Government, obtained by KEI
2021
KEI-NIH FOIA Lawsuit for NIH-FNIH Correspondence on COVID-19 Partnership - October 2023 Production
US Government, obtained by KEI
2023
KEI NIH FOIA ACTIV Partnership October 2022 Production
US Government, obtained by KEI
2022
2020 Setembro 24
Hoje na História
2020
Solo Di Pueblo (11 Juni 2020)
Solo di Pueblo
2020
Amigoe - Aruba (23 Oktober 2014)
Amigoe Aruba
2014
Paul Stoffels - Wikipedia
Paul Stoffels · Contents · Career · See also · References · Sources · External links.
Dr. Paul Stoffels, Vice Chairman of the Executive Committee ...
Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021.
'Gilead wants us to rebuild': Why Galapagos can't go extinct
CEO Paul Stoffels has left, and his cell therapy strategy has been scrapped. So what happened to Galapagos?
Stoffels To Depart Galapagos, Short of Five-Year Mission To ...
Paul Stoffels left his perch as J&J's chief scientific officer in 2022 to replace Galapagos' founding CEO Onno van de Stolpe.
Paul Stoffels - NYAS - The New York Academy of Sciences
Paul Stoffels is Chief Scientific Officer at Johnson & Johnson. As such, he is focused on leading global teams to discover and develop new and innovative ...
Galapagos Announces Executive Leadership Updates
Dr. Paul Stoffels, Chair and CEO of Galapagos, plans to retire as CEO upon appointment of successor in the next 12 months and plans to continue as Chair of the ...
Paul Stoffels - BIO International Convention
Dr. Paul Stoffels joined Galapagos as CEO* in April 2022. Prior to that, he was Vice Chairman of the Executive Committee and CSO of Johnson & Johnson, ...
Toronto Introduction with Paul Stoffels
Dr. Paul Stoffels, Vice Chair of the Executive Committee and Chief Scientific Officer at Johnson & Johnson taps into his own experience as a former ...
Paul Stoffels | World Economic Forum
Paul Stoffels. Leader driving transformational innovation to bring years of life and quality of life to millions of people around the world. Studied medicine ...
Paul Stoffels - Fast Company
Paul Stoffels ... Under CEO Paul Stoffels, the Belgian pharma company is testing a device that manufactures personalized cancer therapies in hospitals, bringing ...
Paul Stoffels of Galapagos in Profile - PharmaBoardroom
Dr Paul Stoffels is now looking to reshape the future of cancer care with the previously struggling biotech he helped co-found in 1999, Galapagos.
Paul Stoffels | pharmaphorum
Paul Stoffels is bringing a nine-year tenure as head of R&D at Johnson & Johnson to a close, announcing plans to retire at the end of the year.
Paul Stoffels on Building the Innovation Ecosystem at Galapagos
Paul Stoffels' return to Galapagos might be the biotech story of a generation. Simultaneously a founding father and returning champion, Stoffels' second ...
Paul Stoffels - Paul Janssen Futurelab Leiden
Paul Stoffels joined Galapagos as Chief Executive Officer in April 2022, and is an executive member and the Chairman of our Board of Directors since 26 ...
Paul Stoffels, J&J's former top scientist, to lead Galapagos
Paul Stoffels, the former chief scientific officer of Johnson & Johnson, will take over as CEO of the Belgium-based drugmaker Galapagos, ...
Paul Stoffels | IFPMA
Areas of work · Initiatives · About us · Members · Careers · News · Publications · Press briefings · Events · Contact us.
Paul Stoffels - IMDb
Self - Chief Scientific Officer, Johnson & Johnson(as Dr Paul Stoffels). 2021 • 1 ep. Credits. Edit · IMDbPro. Self. Previous; 8. Sky News Tonight (2014).
Paul Stoffels to step down as Galapagos CEO - STAT News
Beleaguered Belgian biotech Galapagos said yesterday that its CEO, Paul Stoffels, plans to retire upon the appointment of his successor in the ...
J&J science chief Stoffels to retire after decade ... - Fierce Biotech
Johnson & Johnson Chief Scientific Officer Paul Stoffels, MD, is to retire at the end of the year, ending a nine-year stint at the top of the rejuvenated R&D ...
Galápagos CEO Paul Stoffels on the company's $3.8B cash balance ...
Paul Stoffels describes how his company's decentralized CAR-T process is designed to have a shorter 'brain-to-vein' time, and he comments on the company's ...
Paul Stoffels to retire as CEO of Galapagos but will remain as ...
CEO Paul Stoffels will retire once the board finds a successor, expected within the next twelve months. However, Stoffels will remain the chairman of the board.
International co-operation & vaccines - OECD Events
As Chief Scientific Officer, Paul Stoffels heads Johnson & Johnson's research and product pipeline, and steers the company's global public health strategy.
Drugmaker Galapagos names former J&J exec Paul Stoffels as ...
Belgian drugmaker Galapagos NV (GLPG.AS) on Wednesday named former Johnson & Johnson (JNJ.N) senior executive Paul Stoffels as its chief executive officer.
Paul Stoffels - News, Articles etc.
News stories and articles referencing Paul Stoffels on European Pharmaceutical Review.
Paul Stoffels, CSO of J&J, to retire | C&EN Global Enterprise
Paul Stoffels, Johnson & Johnson's chief scientific officer, will retire at the end of the year. Stoffels is credited with leading the development of J&J's ...
Paul Stoffels on addressing global health challenges
We start with Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson, retiring at the end of this year. Paul, ...